National Vaccine Compensation Program
Executive Summary
The Administrative Conference of the U.S. votes unanimously at its June 14 plenary session to accept its Committee on Governmental Processes' final draft recommendations for improving the National Vaccine Compensation Program. The nine draft recommendations include suggestions that the NVCP be better publicized, that it be given a larger staff and more time to handle its current case load, and that guidelines be established to clarify amounts of compensation. The Conference also agrees that a supplemental report addressing new areas of concern (i.e. the excise tax on vaccines, attorney fees) be prepared for the Conference's next plenary session in December.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth